# TACROLIMUS
> **ANDA206662** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2020-11-10
## Drug
- **FDA Application Number:** ANDA206662
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TACROLIMUS
- **Generic name:** TACROLIMUS
- **Active ingredients:** TACROLIMUS
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLENMARK PHARMS LTD
- **Manufacturer:** NORTHSTAR RX LLC
- **First approval:** 2020-11-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206662)
---
*AI Analytics · CC0 1.0*